MedTrace Logo

Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material

NCT05970536 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-04-18

No results posted yet for this study

Summary

This clinical trial is designed to study and compare the effect of two different types of chelating agents on the vital pulp therapy of mature permanent teeth with irreversible pulpitis using bioceramic material.

Conditions

  • Vital Pulp Therapy

Interventions

OTHER

Apple vinegar or EDTA 17%

Application of each chelating agent for 5 minutes for dentin conditioning followed by placement of MTA on the pulp chamber.

Sponsors & Collaborators

  • Sinai University

    lead OTHER

Principal Investigators

  • Mona R Abo El Wafa Ahmed, PhD · Faculty of Dentistry, Sinai University.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05970536 on ClinicalTrials.gov